Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Net-Income-Applicable-To-Common-Shares" stands at 38.41 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value since 12/31/2017.
Kyowa Kirin Co Ltd's second quarter result of 10.15 Billion JPY for the item "Net Income Applicable To Common Shares" represents an increase of 64.63 percent compared to it's first quarter result.
Also, Kyowa Kirin Co Ltd's second quarter result of 10.15 Billion JPY for the item "Net Income Applicable To Common Shares" represents a decrease of -56.13 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Kyowa Kirin Co Ltd's second quarter result of 38.41 Billion JPY for the item "Net Income Applicable To Common Shares" represents a decrease of -25.27 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -60.53 percent compared to the value the year prior.
The 1 year change in percent is -60.53.
The 3 year change in percent is -38.33.
The 5 year change in percent is -17.95.
The 10 year change in percent is 136.59.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Income Applicable To Common Shares | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Income Applicable To Common Shares | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Income Applicable To Common Shares | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Income Applicable To Common Shares | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Income Applicable To Common Shares | 280,205,508,085.11 |